From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes. [PDF]
Itez GG, Sunguroğlu A.
europepmc +1 more source
Posttuberculosis Consequences on Tuberculosis Prevention Effectiveness and Cost-effectiveness among New Immigrants, Canada. [PDF]
Ainiwaer A +6 more
europepmc +1 more source
Cost-effectiveness analysis of pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2-positive gastric or gastroesophageal junction adenocarcinoma. [PDF]
Yang H, Ge W, Jiang S, Lan X, Du X.
europepmc +1 more source
TACE combined with apatinib versus TACE alone for unresectable hepatocellular carcinoma in China: a cost-effectiveness and budget impact analysis. [PDF]
Zhang Y +4 more
europepmc +1 more source
Omnipod 5 Delivers Superior Economic Value Compared to Multiple Daily Injections: A Cost-Effectiveness Analysis in Adults With T1D From a Payer Perspective in Sweden. [PDF]
Jendle J +5 more
europepmc +1 more source
Cost-effectiveness of finotonlimab plus bevacizumab versus sorafenib as first-line therapy in unresectable hepatocellular carcinoma in China. [PDF]
Xu H +5 more
europepmc +1 more source
Optimal Deployment of Gonorrhoea Point-of-Care Tests: Modeling the Potential Impact of Diagnostic Confirmation Testing and Screening Strategies Across Five Priority Populations in Kenya. [PDF]
Michalow J +5 more
europepmc +1 more source
Cost-effectiveness analysis of the early transition from microscopic to biportal endoscopic unilateral laminectomy bilateral decompression. [PDF]
Kwon SE +10 more
europepmc +1 more source

